Objective To examine associations of Hla class i and class ii alleles with ankylosing spondylitis (aS) in three cohorts of patients of European, asian and african ancestry. Methods Hla-a, Hla-B, Hla-c, Hla-dRB1, Hla-dQB1 and Hla-dpB1 alleles were genotyped in 1948 unrelated white and 67 african-american patients with aS from the prospective Study of outcomes in ankylosing Spondylitis cohort, the north american Spondylitis consortium and australo-anglo-american Spondyloarthritis consortium, 990 white and 245 african-american controls and Hla-B alleles in 442 Han chinese patients with aS and 346 controls from Shanghai and gansu, china. in addition to the case:control analyses, HLA-B*27-negative patients with aS were analysed separately, and logistic regression and 'relative predispositional effects' (RpE) analyses were carried out to control for the major effect of HLA-B*27 on disease susceptibility.
HLA class I genes (HLA-A, HLA-B and HLA-C) and HLA class-II genes (HLA-DRA1, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1) encode cell-surface molecules that play an essential role in the immune defence against intracellular infections and in initiating an immune response to invading pathogens, respectively. Linkage disequilibrium (LD) with HLA-B*27 makes it difficult to resolve whether they play an independent role themselves, which would provide additional clues to AS pathogenesis, and potentially serve as biomarkers of diagnosis. Studies of direct HLA typing to date have been small and underpowered, providing inconsistent results.
Recently 18 19 In a Korean study, imputation was used to additionally show that HLA-C*15:02 is associated with AS susceptibility. 19 The purpose of this study was, in the largest reported series of patients to date for directly genotyped HLA alleles, to examine the relative contributions of HLA-class I and class II alleles, analysing overall disease associations and conditioning on the presence of HLA-B*27 in three ethnic groups: 1948 whites of European ancestry, 442 Han Chinese and 67 African-Americans, the latter never having been examined for MHC associations (other than HLA-B*27 per se) previously.
MeTHOdS

Patient enrolment
White patients with AS in this study came mostly from the Prospective Study of Outcomes in Ankylosing Spondylitis (PSOAS) cohort, 20 a multiethnic study conducted at four US academic institutions (The University of Texas Health-McGovern Medical School (UTH-H), Cedars-Sinai Medical Center, the University of California at San Francisco and the National Institutes of Health Clinical Center) and from The North American Spondylitis Consortium (NASC) (n=408). 21 The black patients included 53 from the PSOAS study, 7 from NASC and 7 other either from patients followed from the outpatient clinics at UTH or referred by Dr Joel Taurog from the University of Texas Southwestern Medical School. All cases met modified New York criteria for AS. 22 Controls were self-identified whites from the USA with no history of rheumatic disease obtained from unaffected non-consanguineous spouses or household or friend controls the Scleroderma Family Registry and DNA repository 23 or the NASC 21 (unrelated spouses or friends-75%) or from University of Texas-Houston Division Controls from Texas (25%). It should be noted that both the NASC and Scleroderma Family Registry controls and families came from all over the USA, although were enriched from Texas and California (NASC) and from Texas, Maryland, Pennsylvania and Michigan (Scleroderma Family Registry). 23 Approximately one-third of the US patients with AS were probands in the NASC study and 2/3 came from the PSOAS study (from which approximately half came from California, 30% from Texas and 20% from the Mid-Atlantic region). All controls were screened by questionnaire for the presence of autoimmune disease or spondyloarthritis and were excluded if having such. For the HLA-B locus analyses, an additional 555 white British and Australian patients with AS from the Australo-Anglo-American Spondylitis Consortium were also analysed. HLA-B locus typing from 442 Han Chinese patients with AS and 346 unrelated Chinese controls were analysed by the same statistical approaches. Though some of the HLA-typing was reported previously by us, 24 additional statistical analyses were carried out for the present study on a significantly larger AS cohort heretofore unreported. The patients with AS came from the clinics and hospitals in Shanghai and Jiangsu Province of China and the Chinese controls (who were free of any history of rheumatic disease) were obtained from a study project of Chinese population genetics at Fudan University in Shanghai. All subjects provided written informed consent. The study was approved by the Institutional Review Boards of all participating medical centres.
HLA genotyping
Single Stranded Conformational Polymorphism (SSCP) typing, of HLA-A, HLA-B and HLA-C alleles, was performed using commercially available kits (Dynal) on genomic DNA extracted from peripheral blood. HLA-DRB1, HLA-DQA1, HLA-DQB1 and HLA-DPB1 typing was performed by standard oligotyping techniques with high resolution HLA-DRB1 typing further achieved by sequence analysis of PCR-amplified HLA-DRB1 exon 2, except for 18 of the African-American patients with AS, where the MHC class II alleles were determined by SSCP typing using commercially available kits (One Lambda). Genomic DNA from the Chinese patients with AS and controls underwent the allele-specific PCR using primers supplied in the SeCore kits and then were followed by sequencing exons 2 and 3 of the HLA-B gene. The HLA SBT uTYPE 6.0 program (Life Technologies) was used in sequencing analysis and assigning HLA-B alleles. The HLA-B genotyping in HLA-B*40 carriers was confirmed with sequence-based typing using SeCore Kits (Life Technologies, USA). The HLA SBT uTYPE 6.0 program (Life Technologies) was used in sequencing analysis.
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Statistical analysis
We constructed 2×2 tables and tested the proportion of alleles in cases vs controls with adjusted Χ 2 test using EPI-INFO ( cdc. gov/ epiinfo/ index. html). Another method of 'adjusting' for the effect of HLA-B*27 at the HLA-B locus is to mask the HLA-B*27 alleles and analyse the remaining alleles for association with phenotype by comparing their frequencies (relative predispositional effects analysis (RPE)). 25 26 Typically, RPEs are assessed by sequentially removing the alleles with the largest effect among those remaining. 25 Such a procedure has no impact on loci other than HLA-B, as we are not removing individuals, but rather alleles. In addition to the univariable associations of each allele with AS, interaction effects between each allele and HLA-B*27 in relation to AS were examined using logistic regression models where the effects of each allele on AS were estimated for HLA-B*27-negative and positive patients separately. For the HLA-B analyses, this study has 94% power to detect an association with an additive OR of 1.5 for an allele with minor allele frequency of 0.1 at nominal significance.
reSuLTS
The white patients in the PSOAS and NASC cohorts were strikingly similar in their clinical features, with psoriasis occurring in 10.4%, Crohn's disease in 5.9%, ulcerative colitis in 3.5% and reactive arthritis in 5.0%. Minor differences between the two cohorts included a slightly lower frequency of HLA-B*27 (85.4%) and uveitis (37%) in the PSOAS cohort compared with 98.5% and 44%, respectively, in the probands from the NASC cohort (the latter enriched for multicase families). The prevalence of HLA-B*27 and uveitis is higher in familial AS. 27 Among the 61 blacks with AS studied who had clinical information available, uveitis occurred in 37.7%, psoriasis in 10.2% and inflammatory bowel disease in 11.5%.
Examination of HLA-A, HLA-B and HLA-C allele frequencies in all white patients with AS and controls showed a number of highly significant associations at each locus (table 1) . HLA-B*27 occurred in 87.8% of the white patients with AS compared with 7.6% of controls (p<1×10 -9 , OR=87.7, 95% CI 66.8 to 115.0), while HLA-B*27 homozygosity occurred in 3.5% of patients and 0.1% of controls (p<1×10 -9 , OR=35.9, 95% CI 4.96 to 258.0) (data not shown- n/a n/a n/a n/a n/a n/a *27:02 10.87 1×10 -15 n/a n/a n/a n/a n/a n/a *27:04 13.62 3×10 -4 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
dISCuSSIOn
HLA-B*27 is the major genetic association with AS in all major ethnic groups. Association of other MHC Class I and II loci with either AS specifically 3-8 10-12 or spondyloarthritis in general 2 9 have been suggested, but have been confounded due to LD between HLA-B and the MHC class II loci. In this study, by conducting stratified analyses of HLA-B*27, we have shown associations with other MHC alleles that cannot be attributed to LD with HLA-B*27 in a moderately large number of patients with AS from three ethnic groups. This study also analyses these alleles in the largest collection of HLA-B*27-negative patients with AS reported to date. We confirm by direct HLA typing some of the associations we previously reported by imputation. 19 HLA-B60 is a serologically defined specificity that correlates at the DNA level with HLA-B*40:01. 28 We were able to confirm the n/a n/a n/a n/a n/a n/a B n/a n/a n/a n/a n/a n/a B*27all 47.6 3.8 23.3 <1×10 -9 n/a n/a n/a n/a n/a n/a B n/a n/a n/a n/a n/a n/a B*27:05 10.9 1.3 9.24 <1×10 -9 n/a n/a n/a n/a n/a n/a B*27:15 1.4 0 n/a 0.04 n/a n/a n/a n/a n/a n/a B 3 0 n/a n/a n/a n/a n/a n/a n/a n/a B n/a: OR is not estimable due to frequencies of zero in contingency tables of AS (case/control) and each allele (-/+). Significant associations are highlighted in bold numbers. *Significant interaction effect found with B*27 (-/+). †Significant interaction effect found with B*27 (-/+). AS, ankylosing spondylitis.
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association with HLA-B*40:01 with AS in three ethnic groups. In this study, the largest to date employing direct HLA-typing, we were able to confirm the positive association with HLA-B60 (B*40), especially B*40:01, seen in other studies of whites by direct typing [4] [5] [6] [7] and by imputed alleles 19 and of Taiwanese Chinese. 8 We were also able to confirm the negative association with HLA-B*07 and B*57 that we reported previously in whites by imputation 19 and in the case of B*07 in Han Chinese by DNA sequencing. 24 The association seen with HLA-B*14, although only by RPE analysis, is compatible with what has been observed in French SpA families 2 as well as in African blacks. 3 The association with HLA-B*38 seen most strikingly in HLA-B*27-negative patients is interesting, given its known association with psoriatic arthritis, 29 although this was not seen in the Chinese cohort, where a weak association was described with HLA-B*39 (HLA-B*38 and B*39 being 'splits' of the parent specificity HLA-B*16 (http:// hla. alleles. org/ antigens/ broads_ splits. html).
We observed an association with HLA-A*02 in the overall cohort that was not seen in the smaller HLA-B*27-negative cohort. This is compatible with the independent association with HLA-A*02:01 that we observed in a much larger patient cohort by imputation, 18 although in the current study we were not able to resolve the association to the 4-digit level. Associations with HLA-DRB1*01 and HLA-DRB1*04:04 seen here have previously been described in UK patients with AS and from French spondyloarthritis families, 2 10 although the lack of confirmation in HLA-B*27-negatives does not allow us to rule out that this may reflect LD with HLA-B*27. Similarly, the association with HLA-DRB1*01:03 that we observed by imputation 19 was again seen here, but was not seen in the HLA-B*27 negatives. HLA-DRB1*01:03 is also strongly associated with inflammatory bowel disease, 30 in particular where associated with peripheral spondyloarthritis. 31 On the other hand, the decreased frequency of HLA-DRB1*15:01 and its linked allele DQB1*06:02 overall and in the HLA-B*27 negatives confirms what we have observed by imputation analysis in a larger cohort, 19 now seen by direct HLA typing. An increased frequency of HLA-B*14 has been observed in French SpA families 2 and in African patients with AS 3 in other studies. We were not able to confirm all the associations by direct HLA typing we previously described by imputation. 19 In some cases, even with the rather large number of patients studied (1948 whites), given the low ORs (<1.5), there may have not have been adequate power. Alternatively, although the patients and controls were from all over the USA, ancestry informative markers were not examined in the controls and we cannot rule out potential stratification issues. We previously described an association with HLA-B*51 by imputation, seen only in a conditional regression analysis, which we could not confirm here, even by RPE analysis. However, we did find an association with HLA-B*52 in whites, both in the HLA-B*27 negatives and in the overall cohort. HLA-B*51 and B*52 are well-recognised 'splits' of the parent specificity HLA-B5 (http:// hla. alleles. org/ antigens/ broads_ splits. html) and although HLA-B*51 was decreased overall, it was increased in frequency in the HLA-B*27 negatives and by RPE analysis, although not significantly. HLA-B*51 was significantly reduced in the Chinese cohort overall, but having controlled for the presence of HLA-B*27 by RPE, no association was observed. We were unable to establish an independent association with HLA-B*13, an allele long associated with psoriasis, described previously by imputation in whites. 19 However, as with HLA-B*51, HLA-B*13 was reduced in the overall Han Chinese dataset, but having controlled for HLA-B*27, no association was observed.
HLA-B*47, observed by imputation as AS-associated, 19 only occurred in five patients with AS and hence was too uncommon to establish as an AS association (data not shown).
The association of HLA-DPB1*03:01 with AS seen in whites further extends what was demonstrated previously in smaller cohorts. 11 12 This is compatible with the association of SNPs around the HLA-DPB1 locus recently established by imputation. 19 We did not examine HLA-DPA1 alleles and so could not confirm the associations with HLA-DPA1*01:02 and DPA1*01:03 reported by Díaz-Peña et al. 12 However, we did not observe any association with HLA-DPB1*13:01 that was seen in their cohort.
We could not confirm some other associations described in smaller AS or SpA cohorts elsewhere [32] [33] [34] perhaps due to clinical heterogeneity. One small recent study of HLA-A, HLA-B, HLA-C and DRB1 alleles in 75 Moroccan patients with AS reported an allele frequency of HLA-B*27 of 32%, with associations also
